This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
Men's Health Weekly
Uroalerts Men's Health Weekly
July 14, 2025
Videos
Peer-to-Peer Clinical Conversations
Urinary and Gut Microbiome Contribute to Androgen Production in Cancer Patients - Karen Sfanos & Jason Ridlon
Karen Sfanos
Andrea Miyahira interviews Karen Sfanos and Jason Ridlon about a Nature Microbiology paper on bacterial androgen production.
View
Androgen Receptor Inhibition and MHC Class 1 Expression in Prostate Cancer - Lisa Chesner
Lisa Chesner
Andrea Miyahira speaks with Lisa Chesner about the relationship between androgen receptor inhibition and MHC class I expression in prostate cancer.
View
Beyond the Abstracts
Minimal Approach to Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia: Is Less More? - Beyond the Abstract
Xipag® for LUTS Management in BPH Patients: Evaluating a Novel Nutraceutical Approach - Beyond the Abstract
Conference Coverage
ASCO GU 2025: Landscape of New Trials and Targets in Refractory Germ Cell Tumors
ASCO GU 2025: Primary Retroperitoneal Lymph Node Dissection in Stage II Seminoma: Management Strategies and Current Controversies
ASCO GU 2025: High-Dose Chemotherapy in Testicular Cancer: Current Evidence and Clinical Indications
SUO 2024: Top Papers in Testicular Cancer 2024
SUO 2024: Spotting Metastatic Masqueraders: How to Avoid Inappropriate Chemotherapy Administration for Testicular Cancer
Articles
Editor Selected Abstracts and Commentaries
Androgen Deficiency
A cross-sectional survey of experiences and outcomes of using testosterone replacement therapy in UK men.
Male Infertility
The Utility of Sperm DNA Fragmentation as a Diagnostic Tool for Male Infertility and Its Predictive Value for Assisted Reproductive Technology Outcomes.
Transcriptome sequencing reveals significant RNA variation in human sperm samples.
Comparing remote smartphone-based semen assessments with laboratory evaluations in men unselected for fertility concerns.
The effects of kidney transplantation on sex hormones, sperm parameters, and fertility rate in males: A systematic review.
Peyronie's Disease
Review of Current Non-Invasive Peyronie's Disease Management: A Changing Reality.
Prostatitis
Three-Glass Test to Culture Prostate Secretion and Semen of Chronic Prostatitis Patients.
Erectile Dysfunction
Low-intensity shockwave therapy for erectile dysfunction.
Efficacy of Chinese herbal medicine in the treatment of anxiety and depression in male sexual dysfunction: a systematic review and meta-analysis.
Surgeon-led vs. nurse-led postoperative follow-up after dilep: impact on erectile function recovery and patient-reported outcomes.
BPH - Benign Prostatic Enlargement
Efficacy of Holmium Laser Enucleation of the Prostate in Patients With Detrusor Underactivity or Acontractile Bladder.
Prostate artery embolization for benign prostatic hyperplasia: a retrospective single-center study of clinical outcome.
Bladder neck contracture post-treatment for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized clinical studies.
Niche No More? Mapping US Trends and Regional Disparities in Holmium Laser Enucleation of the Prostate from 2018 to 2022.
Thulium fiber laser versus holmium MOSESTM laser enucleation of the prostate for the treatment of benign prostatic hyperplasia: a randomized prospective clinical study.
Penile & Urethral Cancers
Penile Cancer Profile in a Central European Context: Clinical Characteristics, Prognosis, and Outcomes-Insights from a Polish Tertiary Medical Center.
RNA-seq of penile squamous cell carcinoma shows ODC1 overexpression is associated with worse overall survival.
Testicular Cancer
A study of subjective memory impairment in long-term testicular cancer survivors.
Near-complete resolution of tumour thrombus in a patient with advanced non-seminomatous germ cell tumour: a multidisciplinary approach without surgical intervention.
Mapping regional disparities in testicular cancer mortality across Spain (2004-2023).
Usefulness of apparent diffusion coefficient values and magnetic resonance imaging histogram analysis for identifying histological types of preoperative testicular tumors.
Robotic Retroperitoneal Lymph-Node Dissection for Testicular Cancer: Initial Experience - Beyond the Abstract
Prostate Cancer
Is [177Lu]Lu-PSMA-617 Redefining Value in mCRPC Care? A Meta-Analysis of Clinical and Economic Endpoints.
Efficacy of Anti-PD-(L)1 Immunotherapy in Patients with DNA Mismatch Repair-deficient Metastatic Castration-resistant Prostate Cancer.
Clinical and Transcriptomic Characterization of Metastatic Hormone-Sensitive Prostate Cancer Patients with Low PTEN Expression.
Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence After Prostatectomy: STARR (NCT05455736): An Early Analysis from the STARR Trial.
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis.
Treatment of biochemical recurrence after primary therapy with curative intent.
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
Acute toxicity of SBRT in localized prostate cancer: A Spanish multicenter study.
Survival outcomes for men with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination deficiencies (HRD) treated with radium 223: Princess Margaret Cancer Centre (PMCC) experience.
Plasma epigenomic profiling reveals treatment-emergent squamous transformation in prostate cancer.
Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis.
U.S. FDA Grants Artera Breakthrough Device Designation for AI-Powered Software Transforming Prostate Cancer Care
Human kallikrein 2: A novel lineage-specific surface target in prostate cancer.
AI lesion tracking in PET/CT imaging: a proposal for a Siamese-based CNN pipeline applied to PSMA PET/CT scans.
What's in a name? Why differentiation between biochemical recurrence and metastatic prostate cancer matters.
Cell-free DNA whole-genomes reveal chromosomal rearrangements associated with heterogeneity and stem cell-like castration-resistant prostate cancer.
Polygenic Risk Scores for Prostate Cancer: Comparative Evaluations in UK and Australian Cohorts.
Usefulness of free PSA ratio to enhance detection of clinically significant prostate cancer in patients with PI-RADS
Guideline of guidelines: a critical appraisal of the evidence for PSA retesting intervals.
Utilization, Acute Complications, and Delays in Treatment Associated with Rectal Spacers for Prostate Cancer Radiotherapy.
Patient-Reported Quality of Life in PROFIT, a Phase 3 Randomized Clinical Trial Evaluating Moderately Hypofractionated Radiotherapy for Intermediate-risk Prostate Cancer - Beyond the Abstract
Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysis.
Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol.
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer.
External Validation on a Japanese Cohort of a Computer-Aided Diagnosis System Aimed at Characterizing ISUP ≥ 2 Prostate Cancers at Multiparametric MRI.
Should we redefine the Phoenix criteria for biochemical recurrence after primary radiotherapy?
Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data.
Immunotherapy in metastatic prostate cancer.
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era.
Generative Artificial Intelligence in Prostate Cancer Imaging.
Optimizing Biopsy Decisions in PI-RADS 3 Lesions: Cross-Institutional Validation of a Local Clinical Risk Model - Beyond the Abstract
GLP-1 Agonist Use Among Men with Localized Prostate Cancer: A Narrative Review and Rationale for Prospective Clinical Trials - Beyond the Abstract
PSMA MRI Guided Prostate SABR ARGOS-CLIMBER Phase I/II Trial: A Primary Endpoint Analysis - Beyond the Abstract
Comparative Adverse Event Profiles of Triplet Therapy Versus Docetaxel-Based Therapy in Patients with Metastatic Prostate Cancer: A Multicenter Retrospective Study - Beyond the Abstract
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry Study - Beyond the Abstract
CONNECT WITH US
Questions or Comments? Email us at
editors@urotoday.com
Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2025 Digital Science Press, LLC
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free